Home Cart Sign in  
Chemical Structure| 154-69-8 Chemical Structure| 154-69-8

Structure of Tripelennamine HCl
CAS No.: 154-69-8

Chemical Structure| 154-69-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tripelennamine HCl is an antagonist of H1-receptor that used as a psychoactive drug with antipruritic activity.

Synonyms: Pyribenzamine HCl; Tripelennamine hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tripelennamine HCl

CAS No. :154-69-8
Formula : C16H22ClN3
M.W : 291.82
SMILES Code : CN(C)CCN(CC1=CC=CC=C1)C2=NC=CC=C2.[H]Cl
Synonyms :
Pyribenzamine HCl; Tripelennamine hydrochloride
MDL No. :MFCD00012815
InChI Key :FSSICIQKZGUEAE-UHFFFAOYSA-N
Pubchem ID :9066

Safety of Tripelennamine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Tripelennamine HCl

GPCR

Isoform Comparison

Biological Activity

Target
  • H1 receptor

    H1 receptor, IC50:30 μM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00316381 Myocardial Infarction Not Applicable Completed - Poland ... More >> III Division of Cardiology Silesian School of Medicine Katowice, Poland, 40-653 Jagiellonian University Institute of Cardiology Krakow, Poland, 31-202 Poznan University of Medical Sciences II Clinic of Cardiology Poznan, Poland, 61-701 National Institute of Cardiology Warszawa, Poland, 04-628 Less <<
NCT01861548 - Completed - Poland ... More >> Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology Lodz, Poland, 91-348 Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland Lodz, Poland, 93-513 Less <<
NCT00620217 Coronary Artery Disease Phase 2 Completed - Poland ... More >> Institute of Cardiology Warsaw, Poland, 04-628 Less <<
NCT00620945 Congenital Heart Surgery ... More >> Cardiopulmonary Bypass Less << Not Applicable Terminated(New protocol now be... More >>ing used for cardiopulmonary bypass) Less << - -
NCT00620945 - Terminated(New protocol now be... More >>ing used for cardiopulmonary bypass) Less << - -
NCT03272334 Metastatic Breast Cancer Phase 1 Phase 2 Recruiting October 30, 2027 United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Melissa Otoya, MSN-CNL    434-982-3365    mo9w@virginia.edu    Contact: Lawrence Lum, MD, DSc    434-243-1375    lgl4f@virginia.edu Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.43mL

0.69mL

0.34mL

17.13mL

3.43mL

1.71mL

34.27mL

6.85mL

3.43mL

References

 

Historical Records

Categories